Erik Emerson

Erik Emerson

Director Ejecutivo en GLUCOTRACK, INC. .

Fortuna: 458 612 $ al 31/08/2026

55 años
Health Technology
Consumer Services

Perfil

Mr. Erik Emerson is a Chief Executive Officer & Director at GlucoTrack, Inc. and a Chief Executive Officer & Director at Lokahi Therapeutics, Inc. He is on the Board of Directors at GlucoTrack, Inc. and Lokahi Therapeutics, Inc. Mr. Emerson was previously employed as a President & Director by Apimeds Pharmaceuticals US, Inc., a Chief Commercial Officer by Odyssey Health, Inc., a Chief Commercial Officer by Mezzion Pharmaceuticals, Inc., a President & Chief Executive Officer by Symplmed Pharmaceuticals LLC, a Senior Director-Commercial Development by XOMA Corp., and a Marketing Director by Gilead Sciences, Inc. He also served on the board at Adhera Therapeutics, Inc. He received his undergraduate degree from the University of Oregon.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
4,97 %
15/10/2025 75.000 ( 4,97 % ) 291 000 $ 31/08/2026
10/08/2026 39.438 ( 4,94 % ) 167 612 $ 31/08/2026

Cargos activos de Erik Emerson

EmpresasCargoInicio
GLUCOTRACK, INC. Director Ejecutivo 14/07/2026

Antiguos cargos conocidos de Erik Emerson.

EmpresasCargoFin
ODYSSEY HEALTH, INC. Corporate Officer/Principal 01/10/2023
Corporate Officer/Principal 01/01/2020
ADHERA THERAPEUTICS, INC. Director/Miembro de la Junta 19/12/2019
Director Ejecutivo 01/05/2018
Ver el detalle de la experiencia de Erik Emerson.

Formación de Erik Emerson.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

56

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology